G1 and G2 ApolipoproteinL1 modulate macrophage inflammation and lipid accumulation through the polyamine pathway
Chronic kidney disease (CKD) affects approximately 10% of the global population, and more than 14% of the United States population (1, 2). Within CKD, there is a disparity of greater disease prevalence among the US African American population (3). Beyond …